financial results
Sarepta Pursues Efficiency Measures Amid $1 Billion Debt Due in 2027
Sarepta Therapeutics; debt 2027; efficiency measures; ELEVIDYS; cost savings; restructuring; financial results 2025; FDA; Duchenne muscular dystrophy; stock decline
Imunon Halts COVID-19 Vaccine Program, Seeks Partner Due to Financial Struggles
Imunon; COVID-19 vaccine; IMNN-101; deprioritization; cash crunch; partnership; financial results
AstraZeneca Beats Q2 Estimates on Strong Cancer Drug Sales
AstraZeneca; Q2 2025; cancer drug sales; oncology portfolio; Tagrisso; Imfinzi; Enhertu; financial results
Astellas Pharma Announces Major Management Restructuring Amid Strong Financial Performance
Astellas Pharma, management restructuring, financial results, executive appointments, pharmaceutical industry
Pharmaceutical Giants Eli Lilly and Novo Nordisk Face Challenges Despite Strong Sales Growth
Eli Lilly, Novo Nordisk, Q3 2024 financial results, Obesity drugs, Weight loss therapies, Pharmaceutical industry challenges, Market competition, Supply pressures, Pricing issues